The Enterprise Value as of December 2025 (TTM) for Alphamab Oncology (9966.HK) is 9.16B

According to Alphamab Oncology’s latest financial reports and current stock price. The company's current Enterprise Value is 9.16B. This represents a change of 167.79% compared to the average of 3.42B of the last 4 quarters.

Alphamab Oncology (9966.HK) Historical Enterprise Value (quarterly & annually)

How has 9966.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of Alphamab Oncology over the last ten years is 7.95B. The current 9.16B Enterprise Value has changed 11.42% with respect to the historical average. Over the past ten years (40 quarters), 9966.HK's Enterprise Value was at its highest in in the June 2021 quarter at 18.65B. The Enterprise Value was at its lowest in in the January 2017 quarter at 0.

Alphamab Oncology (9966.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alphamab Oncology Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Alphamab Oncology (9966.HK) Average Enterprise Value

How has 9966.HK Enterprise Value performed in the past?

The current Enterprise Value of Alphamab Oncology (9966.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Alphamab Oncology (9966.HK) Enterprise Value vs. Peers

How is 9966.HK’s Enterprise Value compared to its peers?

Alphamab Oncology’s Enterprise Value is greater than HBM Holdings Limited (1.18B), less than Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (11.81B), greater than Shanghai Haohai Biological Technology Co., Ltd. (7.21B), less than Nanjing Leads Biolabs Co Ltd (0), greater than Abbisko Cayman Limited (7.78B), less than Lepu Biopharma Co., Ltd. (10.08B), greater than CARsgen Therapeutics Holdings Limited (8.02B), greater than Beijing Chunlizhengda Medical Instruments Co., Ltd. (8.10B), greater than CStone Pharmaceuticals (7.46B), less than Ascletis Pharma Inc. (10.37B),

Build a custom stock screener for Alphamab Oncology (9966.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alphamab Oncology using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alphamab Oncology (9966.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alphamab Oncology or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.